Gregory J. Tibbitts - 13 Feb 2026 Form 4 Insider Report for MAINZ BIOMED N.V. (MYNZ)

Role
Director
Signature
/s/ Gregory Tibbits
Issuer symbol
MYNZ
Transactions as of
13 Feb 2026
Net transactions value
$0
Form type
4
Filing time
19 Feb 2026, 17:16:06 UTC
Previous filing
26 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Gregory J. Tibbitts filed Form 4 for MAINZ BIOMED N.V. (MYNZ) on 19 Feb 2026."

Quick Takeaways

  • This page summarizes Gregory J. Tibbitts's Form 4 filing for MAINZ BIOMED N.V. (MYNZ).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 19 Feb 2026, 17:16.

What Changed

  • Previous filing in this sequence was filed on 26 Jan 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Tibbitts Gregory J Director MAINZ BIOMED N.V., ROBERT KOCH STRASSE 50, MAINZ /s/ Gregory Tibbits 19 Feb 2026 0001326220

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYNZ Ordinary Shares Award $0 +45,000 +414% $0.000000 55,875 13 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted shares under Mainz Biomed N.V. 2025 Omnibus Incentive Plan; no cash consideration paid.
F2 10,875 employee stock options were granted and previously reported on a Form 3 filed January 26, 2026.

Sponsored